PDG23 Exploring the Determinants of Pharmaceutical Expenditure Growth: The Case of Cancer Drugs UNDER a Single-Payer System

Abstract

Authors

S.H. Cheng Y.S. Lin

Full Text Cite This Article
Back to Volume 22, Supplemental S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×